Pharmacotherapy for the Treatment of Alcohol, Opioid and Tobacco Use Disorders

Program Details

Presenters: Ngoc Khuyen Tran, M.D.

Provides 1.25 hour of CE/CME credit (Presented on May 5, 2026; Reviewed June 1, 2026; Expires July 1, 2028)


Provides CME credit toward the Nevada State Board of Medical Examiners' requirement for 2 hours of training related to ethics, pain management, or addiction care during each licensure period.

Online CME Credit Fee: $75.00
Credit must be claimed with 30 days of registering.

Overview

This training is brought to you by CASAT, in collaboration with the University of Nevada, Reno School of Medicine, and supported through funding from the Substance Abuse and Mental Health Services Administration (SAMHSA).

This session reviews FDA-approved pharmacotherapies for alcohol, opioid, and tobacco use disorders and provides practical strategies for selecting, initiating, and monitoring these treatments. It emphasizes integrating medications into comprehensive SUD care through individualized treatment planning, management of co-occurring substance use and medical conditions, overdose prevention education, toxicology testing, and diversion risk mitigation.

Presentation materials are not for reproduction or distribution without specific written authorization. The opinions, findings, conclusions, and recommendations expressed in our courses are those of the author(s) and do not necessarily represent the official views of CASAT.

Learning Objectives

Following participation in this course, participants should be able to:

  • Review the mechanism of action of alcohol and discuss FDA-approved pharmacotherapies for AUD
  • Review the mechanism of action of opioids and discuss FDA-approved pharmacotherapy for OUD
  • Review the mechanism of action of nicotine products and discuss FDA-approved pharmacotherapy for nicotine dependence

Program Faculty

Ngoc Khuyen Tran, M.D.: Clinical Assistant Professor of Medicine at the Univeristy of Nevada, Reno School of Medicine